Recipient
The Pembroke Medical Practice
First report 27 Jan 2025•Latest report 27 Jan 2025
Reports, concerns and published responses
This page brings together reports naming this recipient and response statements clearly connected to concerns raised in those reports.
- Reports
- 1
- Published responses
- 0%
- Concerns addressed
- 0
- Stated actions
- 0
Naming this recipient
Found for named reports
Across all linked responses
Described in responses
Reports over time
Reports over time
Reports naming this recipient by issue year.
Evidence profile
Report topics
Share of this recipient’s reports compared with all other recipients.
Topic comparisons are not available in the current evidence snapshot.
Concerns and recipient responses
Statements from The Pembroke Medical Practice linked to the concerns in each report. Select any concern, action or position to view the source wording.
-
Concerns raised4
Failure to achieve clear communication of key information within community mental health teams
Failure to routinely detect Clozapine-associated cardiomyopathies
Limited provision of Clozapine side-effect and red-flag information to patients attending GP practices
Failure to achieve clear communication of key information with other agencies involved in patient care
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
No linked response statementsNo action or position from this recipient is clearly linked to the concerns in this report.
Information checked against published PFD reports and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations
Data last updated 7 September 2026